Related products Tirzepatide/B6 vial $0.00 Tirzepatide/B6 vial $0.00 Tirzepatide/B6 vial $0.00
Next-generation multi-agonist alternatives Tirzepatide was groundbreaking because it targeted two receptors (GLP-1 and GIP) instead of just one
No contamination
Pfizer, Mylan, Novartis, Takeda Pharmaceutical, Teva Pharmaceuticals, Bristol Myers Squibb, AbbVie, Johnson & Johnson, Boehringer Ingelheim, Merck Group, GSK, Amgen, Eli Lilly and Company, Sanofi, AstraZeneca, Saisheng Pharmaceutical, Harbin Pharmaceutical Group Co., Ltd., Zhejiang Hengkang Pharmaceutical Co., Ltd., Libang Pharmaceutical, Beijing Tide Pharmaceutical Co., Ltd
It has been shown to upregulate pathways tied to collagen and glycosaminoglycan synthesis, modulate metalloproteinase (MMP) and tissue inhibitor of metalloproteinases (TIMP) balance, and support antioxidant effects, thereby contributing to matrix organization and structural stability in research settings
Imperacalcin (formerly imperatoxin A), identified from the venom of Pandinus imperator , is the first member of the calcium-targeting toxins to bind to RyR1 with nanomolar affinities (Valdivia et al., 1992)